Xeris Biopharma Holdings, Inc. XERS Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s cash ratio?
- Xeris Biopharma Holdings, Inc. (XERS) reported cash ratio of 0.9× in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s cash ratio changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s cash ratio increased by 53.3% year-over-year, from 0.6× to 0.9×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s cash ratio has grown at a -5.3% compound annual growth rate (CAGR), from 1.3× to 1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.